Mono Pharmacare Profit & Loss Annual

BSE: - | NSE: MONOPHARMA | ISIN: INE0OIP01012 | Sector: -

23.25 -0.75 (-3.13%)Updated : 17 Jun 2025

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	122.34	58.48	36.98	28.27
Total Revenue	122.34	58.48	36.98	28.27
Costof Revenue Total	110.68	53.34	34.69	26.56
Gross Profit	11.66	5.14	2.29	1.71
Selling/ General/ Admin Expenses Total	3.51	1.10	0.62	0.54
Depreciation/ Amortization	0.12	0.10	0.11	0.13
Unusual Expense( Income)	0.00	0.00	0.00	0.00
Other Operating Expenses Total	1.82	1.07	0.39	0.32
Total Operating Expense	116.13	55.61	35.81	27.55
Operating Income	6.21	2.86	1.17	0.72
Interest Inc( Exp) Net- Non- Op Total	-2.85	-1.22	-0.65	-0.64
Other Net	-0.14	0.03	0.03	0.10
Net Income Before Taxes	3.23	1.68	0.55	0.17
Provisionfor Income Taxes	0.77	0.44	0.20	0.07
Net Income After Taxes	2.46	1.23	0.35	0.10
Minority Interest	-0.02	0.00	0.00	0.00
Net Income Before Extra Items	2.44	1.23	0.35	0.10
Net Income	2.44	1.23	0.35	0.10
Total Adjustmentsto Net Income	0.00	-	-	-
Income Availableto Com Excl Extra Ord	2.44	1.23	0.35	0.10
Income Availableto Com Incl Extra Ord	2.44	1.23	0.35	0.10
Diluted Net Income	2.44	1.23	0.35	0.10
Diluted Weighted Average Shares	1.54	1.77	1.77	1.77
Diluted EPS Excluding Extra Ord Items	1.59	0.70	0.20	0.05
Diluted Normalized EPS	1.59	0.70	0.20	0.05
period Length	12.00	12.00	12.00	12.00
period Type	-	-	-	-

*All figures in crores except per share values

Trending Stocks

1,716.60+22.50(1.33%)

1,640.15+16.40(1.01%)

2,264.50+20.85(0.93%)

1,648.85-36.70 (-2.18%)

675.00-11.70 (-1.70%)

Related News